Skip to main content
Clinical Trials/DRKS00004927
DRKS00004927
Completed
N/A

Genetic, age, gender and environmental factors that modify immuno-responses and the development of allergic asthma during the school age in childhood. - AGENDAS

niversitätsklinikum ErlangenAnästhesieAbteilung Molekulare Pneumologie0 sites20 target enrollmentMay 16, 2013
ConditionsJ45Asthma

Overview

Phase
N/A
Intervention
Not specified
Conditions
J45
Sponsor
niversitätsklinikum ErlangenAnästhesieAbteilung Molekulare Pneumologie
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 16, 2013
End Date
October 13, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum ErlangenAnästhesieAbteilung Molekulare Pneumologie

Eligibility Criteria

Inclusion Criteria

  • Written informed consent from the child’s parents/guardian’s
  • \- Age 6\-10 years (beginning at the day of the 6th birthday and ending at the day of the 10th birthday)
  • \- Gestational age 36 weeks or above
  • \- A diagnosis of allergic asthma within the last 2 years or bronchial hyperreactivity
  • \- The child is able to perform a body plethysmography
  • \- The legal custodian has the verbal, writing and mental ability to understand the intent and character of the study
  • Control group:
  • \- Age 6\-10 years
  • \- No history of allergic asthma and bronchial hyperreactivity

Exclusion Criteria

  • \- Severe/brittle asthma
  • \- Other chronic respiratory diseases (CF, BPD, immunodeficiencies) except allergic rhinitis
  • \- Other chronic diseases or chronic medication use except atopic exzema

Outcomes

Primary Outcomes

Not specified

Similar Trials